15 Breast Cancer Patients Benefit from Chemotherapy-Induced Alopecia Prevention Treatments in San Giovanni Rotondo
In a positive development for breast cancer patients, the IRCCS Casa Sollievo della Sofferenza in San Giovanni Rotondo has been able to provide chemotherapy-induced alopecia prevention treatments to 15 patients in the past few weeks. This success was made possible thanks to the Puglia Region’s supply of 2 cooling systems and 10 helmets, which were assigned to the Breast Unit and Medical Oncology of the San Giovanni Rotondo Hospital.
The cooling system consists of a refrigeration unit managed by dedicated software, with the hypothermic cap (“scalp cooler”) constantly lowering the temperature of the scalp by up to 4 degrees centigrade. Oncologist Maria Morritti explained that this system was approved by the American Food and Drug Administration based on clinical studies showing its positive effect on reducing hair loss during chemotherapy.
The treatment, which must be initiated at least half an hour before chemotherapy administration and continued for the entire infusion and even after the treatment, has shown varying levels of success depending on the chemotherapy drug used. However, the overall goal is to offer women with breast cancer the opportunity to prevent alopecia during treatment, thus helping them maintain a sense of normalcy and positivity throughout their journey.
This innovative approach not only provides physical relief but also promotes a positive attitude towards the treatment and the disease, offering patients a sense of support and encouragement during a difficult time. The success of these treatments highlights the importance of continued research and investment in improving the quality of life for cancer patients.